CERT Stock Summary and Trading Ideas (Certara | NASDAQ:CERT)

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Certara trades on the NASDAQ stock market under the symbol CERT.

As of September 3, 2026, CERT stock price declined to $8.13 with 2,025,681 million shares trading.

CERT has a beta of 1.94, meaning it tends to be more sensitive to market movements. CERT has a correlation of 0.12 to the broad based SPY ETF.

CERT has a market cap of $1.24 billion. This is considered a Small Cap stock.

Last quarter Certara reported $93 million in Revenue and $.08 earnings per share. This fell short of revenue expectation by $-5 million and missed earnings estimates by -$.01.

In the last 3 years, CERT traded as high as $19.87 and as low as $4.45.

The top ETF exchange traded funds that CERT belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.

CERT has underperformed the market in the last year with a price return of -23.7% while the SPY ETF gained +21.9%. However, in the short term, CERT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +44.7% vs +2.0% return in SPY. But in the last 2 weeks, CERT shares have been beat by the market, returning -2.8% compared to an SPY return of +0.5%.

CERT support price is $8.07 and resistance is $8.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CERT shares will trade within this expected range on the day.